Published On: Sep 2025
Published On: Sep 2025
According to Business Market Insights' research, the Europe resistant starch market was valued at US$ 3,714.47 million in 2023 and is expected to reach US$ 6,026.50 million by 2031, registering a CAGR of 6.2% from 2023 to 2031. Increasing consumer focus on preventive health and increasing demand for resistant starch in animal feed are among the critical factors attributed to the Europe resistant starch market expansion.
Hectic work schedules and extended working hours have led people to pay less attention to their daily diet, health, and fitness. The lack of a proper diet might lead to various health issues, such as obesity, diabetes, and digestive problems. As a result, people are becoming more focused on preventive health and dietary supplements that offer health benefits without harmful effects. Prebiotics-infused supplements nourish human gut flora and significantly boost their metabolic activity, thereby improving digestion, nutrition absorption, and immune systems while inhibiting harmful microbe growth. Resistant starch as a prebiotic ingredient helps prevent obesity by positively stimulating fermentation by gut microbiota. Resistant starches enhance the body's ability to respond to insulin, enabling the body to manage high blood sugar and reducing the risk of type 2 diabetes, Alzheimer's disease, and heart disease.
Resistant starch used in dietary supplements creates good bacteria after fermentation in the large intestine. This leads to less constipation, lower cholesterol levels, and lower risk of colon cancer. Dietary supplements formulated with resistant starch improve digestion and nutrient absorption and help lower the risk of digestive diseases. Further, consistent and adequate intake of prebiotics lowers the risk of cardiovascular diseases, including coronary heart disease, by reducing low-density lipoprotein (LDL) levels. Thus, rising awareness about preventive health among consumers fuels the resistant starch market growth.
On the contrary, lack of uniformity in regulations hampers the growth of Europe resistant starch market.
Based on form, the Europe resistant starch market is bifurcated into dry and liquid. The dry segment held 67.4% share of the Europe resistant starch market in 2023, amassing US$ 2,345.57 million. It is projected to garner US$ 3,709.06 million by 2031 to expand at 5.9% CAGR during 2023–2031.
Based on type, the Europe resistant starch market is segmented into type1, type2, type3, and type4. The type2 segment held 38.5% share of the Europe resistant starch market in 2023, amassing US$ 1,428.71 million. It is projected to garner US$ 2,413.15 million by 2031 to expand at 6.8% CAGR during 2023–2031.
Based on application, the Europe resistant starch market is segmented into food and beverages, dietary supplements, and animal nutrition. The food and beverages segment held 64.7% share of the Europe resistant starch market in 2023, amassing US$ 2,403.60 million. It is projected to garner US$ 3,954.30 million by 2031 to expand at 6.4% CAGR during 2023–2031. The food and beverages segment is further subsegmented into bakery and confectionery, dairy and frozen dessert, beverages, sweet and savory snacks, and others.
Based on country, the Europe resistant starch market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe held 34.4% share of Europe resistant starch market in 2023, amassing US$ 1,276.49 million. It is projected to garner US$ 1,960.88 million by 2031 to expand at 5.5% CAGR during 2023–2031.
Key players operating in the resistant starch market are Tate & Lyle Plc, Archer-Daniels-Midland Co, Cargill Inc, Ingredion Inc, Arcadia Biosciences Inc, Roquette Freres SA, MGP Ingredients Inc, American International Foods Inc, Crespel & Deiters GmbH & Co KG, Agrana Beteiligungs AG, Lehmann Food Ingredients Ltd, KMC Amba, Emsland-Stärke GmbH, Kono Chem Co Ltd, and BS Starch Chemical Co Ltd, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com